Alzheimer Disease: all 3,765 studies

Page 31 of 38. Open to participants first (881), then studies with results posted, then the rest; newest registration first within each.

• A Positron Emission Tomography (PET) Study to Investigate the Brain Biodistribution of 18F GSK2647544 in Healthy Subjects to Determine Its Ability to Cross the Blood-brain-barrier.TerminatedNCT01924858Phase 1
• The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's DiseaseCompletedNCT01921972Phase 4
• Disrupted Sleep, Neuroendocrine Status and the Behavioral Symptoms of ADCompletedNCT01920672Not applicable
• Safety, Tolerability, and Pharmacokinetics of ABT-354 in Subjects With Mild-to-Moderate Alzheimer's Disease on Stable Doses of Acetylcholinesterase InhibitorsCompletedNCT01908010Phase 1
• Inhalational Anesthesia and Precipitation of Dementia: is There a Link?Status unknownNCT01903421Not applicable
• Patients With Behavioural Symptoms and Hospitalized in Cognitive and Behavioural UnitsCompletedNCT01901263
• Multistimulation Group Therapy for Alzheimer's DiseaseCompletedNCT01893398Not applicable
• Influence of tDCS on Cortical Plasticity in Patients With Dementia of the Alzheimer TypeWithdrawnNCT01887899Not applicable
• A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem HistopathologyStatus unknownNCT01886820Phase 3
• Repetitive Transcranial Magnetic Stimulation for Apathy Treatment in Alzheimer's DiseaseStatus unknownNCT01885806Phase 2
• Study to Evaluate Coconut Oil for Alzheimer's DiseaseTerminatedNCT01883648Phase 2/3
• Neuroelectrical Biomarkers for Alzheimer's Disease StagesCompletedNCT01880151Not applicable
• Alpha-synuclein in Cerebrospinal Fluid to Differentiate Alzheimer's Disease From Lewy Body Disease.Status unknownNCT01876459Not applicable
• Biomarker Study to Diagnose Alzheimer's DiseaseStatus unknownNCT01874418Not applicable
• Masitinib in Patients With Mild to Moderate Alzheimer's DiseaseCompletedNCT01872598Phase 3
• Differential Effects of Various Anesthetic Agents on Cognitive Function in Patients With Alzheimer's DiseaseWithdrawnNCT01870453
• Mirtazapine for Sleep Disorders in Alzheimer's DiseaseStatus unknownNCT01867775Phase 3
• Early Markers of Alzheimer's Disease: Structural and Functional Brain ChangesTerminatedNCT01867372
• Early Markers of Cognitive Change and Alzheimer s DiseaseCompletedNCT01867346
• Safety and Tolerability of AZD0530 (Saracatinib) in Alzheimer's DiseaseCompletedNCT01864655Phase 1
• A Phase I Clinical, Dose Escalation Study of the Safety, Tolerability and Pharmacokinetics of Donepezil Patch in Healthy Male SubjectsCompletedNCT01860625Phase 1
• Efficacy and Safety of MNI-672 SPECT for Detection/Exclusion of Cerebral B-amyloid in AD Subjects Compared to HVs.CompletedNCT01859767Phase 1
• Safety Study of AADvac1, a Tau Peptide-KLH-Conjugate Active Vaccine to Treat Alzheimer's DiseaseCompletedNCT01850238Phase 1
• Effect of Memantine Oral Pump on Language in Patients With Probable Alzheimer's DiseaseStatus unknownNCT01849042Phase 4
• Enhancing Neuroplasticity and Frontal Lobe Function in Patients With Mild Alzheimer's DiseaseCompletedNCT01847586Not applicable
• Evaluating Liraglutide in Alzheimer's DiseaseStatus unknownNCT01843075Phase 2
• Detection of Disease-Related Changes in Pre-Symptomatic Alzheimer's DiseaseStatus unknownNCT01841905
• Escitalopram for the Treatment of Depression in Alzheimer's DiseaseCompletedNCT01841125Phase 4
• Imaging of New Learning in Severe Alzheimer's Disease PatientsStatus unknownNCT01839422Not applicable
• Nuedexta in the Treatment of Pseudobulbar Affect in Patients With Alzheimer's DiseaseTerminatedNCT01832350Phase 4
• PET Imaging Study Using [11C]PIB in Subjects With AD & Healthy VolunteersCompletedNCT01826110Phase 1
• Effect of NeuroAD on the Cognitive Function of Alzheimer PatientsCompletedNCT01825330Not applicable
• Effect of NeuroAD on Alzheimer PatientsCompletedNCT01825317Not applicable
• Predicting the Conversion From Mild Cognitive Impairment to DementiaCompletedNCT01823666
• Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)WithdrawnNCT01822951Phase 4
• Sensory Support Care for Elderly Patients Suffering From Alzheimer'S-type Neurodegenerative DiseaseCompletedNCT01819714Not applicable
• The Study of microRNA 107 (miRNA 107) and Beta-amyloid Precursor Protein-cleaving Enzyme 1 (BACE1) Messenger Ribonucleic Acid (mRNA) Gene Expression in Cerebrospinal Fluid and Peripheral Blood of Alzheimer's DiseaseStatus unknownNCT01819545
• Early Diagnosis of Alzheimer-like Dementia: Benefit of MRI and PET ImagingTerminatedNCT01815112Not applicable
• Curcumin and Yoga Therapy for Those at Risk for Alzheimer's DiseaseStatus unknownNCT01811381Phase 2
• Vanquishing Apathy Through E-inclusion Using Realistic Virtual Environment ProjectCompletedNCT01798199Not applicable
• Impact of Therapeutic Educational Programme on the Alzheimer's Disease Affected Patient's Quality of LifeCompletedNCT01796314Not applicable
• A Two-part Multiple Dose Study to Assess the Safety and Effects of AZD3293 in Healthy Elderly and Alzheimer's PatientsCompletedNCT01795339Phase 1
• Self-consciousness in DementiaTerminatedNCT01782248Not applicable
• The Cognitive Effects of Lorazepam in Healthy Older Individuals With TOMM40 Variable-length PolymorphismsCompletedNCT01780519Phase 1
• Clinical Pathway for Alzheimer's Disease in China (CPAD)CompletedNCT01779310
• The Role of Mid-Life Adiposity in Functional Brain ConnectivityTerminatedNCT01777789
• Central and Systemic Inflammation in Alzheimer's DiseaseCompletedNCT01775696
• New Proteins in Body Fluids as Potential Biomarker for Alzheimer's Disease: a Pilot StudyStatus unknownNCT01773915
• ADVANCE Study: Alzheimer Disease eVAluation iN Clinical PracticECompletedNCT01772095
• Safety and Efficacy of MT-4666CompletedNCT01764243Phase 2
• Experimental Study of the Impact of a Group Therapy Psychological Intervention for Caregivers of Alzheimer's Disease PatientsCompletedNCT01762618Not applicable
• Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001Active, not recruitingNCT01760005Phase 2/3
• Bisnorcymserine in Healthy Adult VolunteersCompletedNCT01747213Phase 1
• Can the Assessment of the Subhippocampal Region Contribute to the Detection of Early Diagnosis of Alzheimer's Disease? A Validation Study Using PET With Florbetapir (AV-45).Status unknownNCT01746706Not applicable
• Therapeutic Effect of Direct Current Stimulation on Cognitive Function of Mild to Moderate Alzheimer PatientsCompletedNCT01746498Not applicable
• Effect of Cerefolin®/CerefolinNAC® on Biomarker MeasurementsCompletedNCT01745198
• Conservation of Praxis in the Food and Alzheimer DiseaseCompletedNCT01743534
• AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label ExtCompletedNCT01741194Phase 2/3
• A Phase 0, Open Label, Multi-center Exploratory and Safety Study of [F-18]T807TerminatedNCT01733355Early Phase 1
• Cerebrospinal Fluid (CSF) Biomarkers Alzheimer's Disease (AD) and Non-AD DementiasCompletedNCT01730430
• Arterial Spin Labeling (ASL) MRI for Cognitive DeclineCompletedNCT01727622
• Effects of Exercise Training in Patients With Mild Cognitive ImpairmentCompletedNCT01724151
• Evaluation of Effects of Multiple Dose Regimens of CHF 5074 on Potential Biomarkers of Neurodegeneration in Subjects With Mild Cognitive ImpairmentWithdrawnNCT01723670Phase 2
• Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical ADCompletedNCT01723553Phase 1
• A Phase 0, Open Label, Multi-Center, Exploratory and Safety Study of [F-18]T808TerminatedNCT01723488Early Phase 1
• An Study to Determine the Bioavailability of E2609 Tablets Compared to Capsules and the Effect of Food on AbsorptionCompletedNCT01716897Phase 1
• Short Term Efficacy and Safety of Perispinal Administration of Etanercept in Mild to Moderate Alzheimer's DiseaseCompletedNCT01716637Phase 1
• Study to Explore the Optimal Dosage/Administration in Alzheimer's DiseaseCompletedNCT01715350Phase 2
• Volunteers Adding Life in Dementia: VALIDCompletedNCT01715181Not applicable
• Human Brain Antioxidants During Oxidative StressCompletedNCT01713816
• Reducing Disabilities in Alzheimer's Disease (RDAD) Translation in Area Agencies on Aging (AAAs)CompletedNCT01708304Not applicable
• Isolated Erythrocyte Membrane Susceptibility to Photo-oxidative Stress in Alzheimer's DiseaseCompletedNCT01707719
• Effects of Triglycerides on Age-Related Cognitive Function Decline in Older SubjectsCompletedNCT01702480Phase 1
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single, Oral Escalating Doses of GSK2647544 in Healthy VolunteersCompletedNCT01702467Phase 1
• A Study of RO4602522 in Patients With Alzheimer Disease and in Healthy VolunteersCompletedNCT01701089Phase 1
• A Trial to Support Caregivers of Patients With Dementia in Italy: the UP-TECH ProjectCompletedNCT01700556Not applicable
• The Long-Term Safety and Efficacy Follow-Up Study of Subjects Who Completed the Phase I Clinical Trial of Neurostem®-ADStatus unknownNCT01696591
• Efficacy and Tolerability of MLC601 in Patients With Mild to Moderate Alzheimer Disease Who Were Unable to Tolerate or Failed to Benefit From Treatment With RivastigmineCompletedNCT01696123Phase 2
• Randomized Trial of Exercise and Social Interaction in a Community-Based Sample of Non-Demented Chinese EldersCompletedNCT01696019Not applicable
• Is There a Relationship Between Previous Exposure to General Anesthesia and the Development of Alzheimer´s Disease?Status unknownNCT01695889
• What Elements of the Design of a Healing Garden Are Used as Landmarks by Patients With Alzheimer's Disease to Locate?CompletedNCT01692977Not applicable
• Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's DiseaseTerminatedNCT01690195Phase 2
• Alzheimer Disease : Rehabilitation's Intervention at HomeTerminatedNCT01689948Not applicable
• Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's DiseaseCompletedNCT01689246Phase 3
• Safety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's DiseaseCompletedNCT01689233Phase 3
• A Study of Brain Aging in Vietnam War VeteransCompletedNCT01687153
• Effect of Physical Exercise in Alzheimer PatientsCompletedNCT01681602Phase 3
• Efficacy and Safety of the PET Imaging Agent [18F]NAV4694 in Subjects With Probable Alzheimer's DiseaseStatus unknownNCT01680588Phase 2
• A Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease TherapyCompletedNCT01677754Phase 2
• Multiple Dose Study of Aducanumab (BIIB037) (Recombinant, Fully Human Anti-Aβ IgG1 mAb) in Participants With Prodromal or Mild Alzheimer's DiseaseTerminatedNCT01677572Phase 1
• This is a Safety and Tolerability Study Evaluating a New Treatment for Subjects With Mild to Moderate Alzheimer's DiseaseTerminatedNCT01676935Phase 2
• Study to Evaluate Dietary Supplementation With a Version of Anatabloc(R) in Subjects With Alzheimer's DiseaseTerminatedNCT01669876Phase 2
• Effectiveness of a Brain-Computer Interface Based System for Cognitive Enhancement in the Normal ElderlyCompletedNCT01661894Phase 1
• Safety, Tolerability, Pharmacokinetics of EVP-0962 and Effects of EVP-0962 on Cerebral Spinal Fluid Amyloid Concentrations in Healthy Subjects and in Subjects With Mild Cognitive Impairment or Early Alzheimer's DiseaseCompletedNCT01661673Phase 2
• Retrieval of Patient Information After DiscontinuationTerminatedNCT01658722
• A Multiple-dose Study of Gantenerumab in Japanese Alzheimer&Apos;s Disease PatientsCompletedNCT01656525Phase 1
• Experimental Study to Validate the "Therapeutic Game" CONEM-BETACompletedNCT01652222Not applicable
• Volunteers Adding Life in DementiaCompletedNCT01646723Not applicable
• Non-expensive and Widely Available Tests as Diagnostic Tools in Dementia and Their Ability to Predict Disease ProgressionStatus unknownNCT01642420
• Markers of Alzheimers Disease After Propofol or Isoflurane AnesthesiaCompletedNCT01640275Phase 1

← Alzheimer Disease overview